We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We may also share information about your use of our site with our social media, advertising and analytics partners. Read more about our Privacy Policy.

I got it!

Orphan Drugs and Rare Diseases

SMi Group is proud to announce it will be hosting the 3rd annual conference on Orphan Drugs and Rare Diseases and bringing together leading experts and companies such as Novabiotics, Pfizer, AstraZeneca, GMP Orphan SAS, Genethon and M&C Saatchi and m

As of January 2014, the EMA lifted the restriction on providing fee reductions to large companies developing new orphan drugs and the Early Access to Medicines Scheme was introduced. Key implementation of this will be a factor into further commercialisation and developments.Based on this information SMi Group is proud to announce it will be hosting the 3rdannual conference on Orphan Drugs and Rare Diseases and bringing together leading experts and companies such as Novabiotics, Pfizer, AstraZeneca, GMP Orphan SAS, Genethon and M&C Saatchi and many more to discuss the latest developments in the market.Benefits of Attending: Hear important insights from Ian Hudson, CEO, MHRA on the Early Access to Medicines Initiative and adaptive licensingFocus on enhancing development pathways, with the growth of the commercial pipeline for orphan drugs and rare diseasesAssess tools for consideration to gain early market access and enhance patient recruitmentInteractive round table discussion led by Dominic Nutt, Director of Communications, The Saatchi Cancer Initiative, M&C Saatchi on creating a culture of innovation in the field of orphan drugs and rare diseases

When

20 Oct 2014 @ 08:00 am

21 Nov 2014 @ 05:30 pm

Duration: 32 days, 9 hours


Where

Holiday Inn Regents Park

24 Carburton Street

Greater London

United Kingdom


Organised by

SMi Group Ltd.

Premium Events in Health

Recent Publications in Health

Recent Videos in Health

Recent News in Health

‘Don’t panic about COVID-19, learn from Latvia,’ says Pabriks https://t.co/MyTxRzHi31

@eaHealthEU - 28 Feb 2020 21:10

The Brief – MEPs have parliamentary, not coronavirus immunity https://t.co/npWjzoeiOz

@eaHealthEU - 28 Feb 2020 18:55

Available on #ECDC website: Checklist for hospitals preparing for the reception and care of #COVID19 patients, bas… https://t.co/WY9XDafd9u

@ECDC_EU - 28 Feb 2020 16:41

Recent Speakers in Health

Premium EventsLearn more ..